Thus, mice overexpressing the human CRP develop more severe AKI by activating Smad3-dependent cell death pathway 68, 70, which is reversed by targeting this pathway with a pharmacological Smad3 inhibitor 68. The gene discussed is SMAD3; the disease is acute kidney injury.